Q Fever
Return to Library
Studies from National Institutes of Health yield new information about q fever
2009 JUN 1 - (NewsRx.com) -- According to a study from the United States, "Coxiella burnetii is an obligate intracellular bacterial pathogen that causes the zoonosis Q fever. While an effective whole-cell vaccine (WCV) against Q fever exists, the vaccine has limitations in being highly reactogenic in sensitized individuals." "Thus, a safe and effective vaccine based on recombinant protein antigen (Ag) is desirable. To achieve this goal, a better understanding of the host response to primary infection and the precise mechanisms involved in protective immunity to C. burnetii are needed," wrote J.G. Shannon and colleagues, National Institutes of Health. The researchers concluded: "This review summarizes our current understanding of adaptive immunity to C. burnetii with a focus on recent developments in the Weld." Shannon and colleagues published the results of their research in Immunologic Research (Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii. Immunologic Research, 2009;43(1-3):138-148). For additional information, contact R.A. Heinzen, NIAID, Coxiella Pathogenesis Sect, Intracellular Parasites Laboratory, Rocky Mt Laboratories, National Institutes of Health, 903 S 4th St., Hamilton, MT 59840, USA. The publisher of the journal Immunologic Research can be contacted at: Humana Press Inc., 999 Riverview Drive Suite 208, Totowa, NJ 07512, USA. Keywords: United States, Hamilton, Biotechnology, Proteomics, Q Fever, Vaccines, National Institutes of Health. This article was prepared by Proteomics Weekly editors from staff and other reports. Copyright 2009, Proteomics Weekly via NewsRx.com.
|
